Irma M Hein1, Pieter W Troost1, Martine C de Vries2, Catherijne A J Knibbe3, Johannes B van Goudoever4, Ramón J L Lindauer1. 1. Department of Child and Adolescent Psychiatry, Academic Medical Center, Amsterdam, The Netherlands. 2. Department of Medical Ethics and Health Law, Leiden University Medical Center, Leiden, The Netherlands. 3. Department of Clinical Pharmacy, St. Antonius Hospital, Nieuwegein, The Netherlands. 4. 1] Department of Pediatrics, Emma Children's Hospital, Academic Medical Center, Amsterdam, The Netherlands [2] Department of Pediatrics, VU University Medical Center, Amsterdam, The Netherlands.
Abstract
BACKGROUND: More pediatric drug trials are needed, but although specific pediatric regulations warrant safety, recruitment of children for these trials remains one of the main difficulties. Therefore, we investigated potential determining factors of nonparticipation in clinical research, in order to optimize research participation of children by recommending improved recruitment strategies. METHODS: Between 1 January 2012 and 1 January 2014, we performed a prospective study among161 pediatric patients, aged 6 to 18 y, who were eligible for clinical research. We quantitatively analyzed the association of potential explanatory variables (e.g., age, cognitive development, experience, ethnicity) with nonparticipation and qualitatively analyzed interviews on reasons for nonparticipation. RESULTS: Sixty percent of the children did not participate in the research project on offer (39% decided not to participate, 21% were indecisive). Lower age, less disease experience, and less complex research with lower risk were predictive for not participating. Time constraint and extra burden were expressed as decisive reasons for not participating. CONCLUSIONS: Strategies to optimize research participation should be aimed at younger children and their families, who are logistically challenged and unfamiliar with health care and research. Recommendations include informing pediatric patients and their families of the value of research; minimizing logistic burdens; and improving accessibility.
BACKGROUND: More pediatric drug trials are needed, but although specific pediatric regulations warrant safety, recruitment of children for these trials remains one of the main difficulties. Therefore, we investigated potential determining factors of nonparticipation in clinical research, in order to optimize research participation of children by recommending improved recruitment strategies. METHODS: Between 1 January 2012 and 1 January 2014, we performed a prospective study among161 pediatric patients, aged 6 to 18 y, who were eligible for clinical research. We quantitatively analyzed the association of potential explanatory variables (e.g., age, cognitive development, experience, ethnicity) with nonparticipation and qualitatively analyzed interviews on reasons for nonparticipation. RESULTS: Sixty percent of the children did not participate in the research project on offer (39% decided not to participate, 21% were indecisive). Lower age, less disease experience, and less complex research with lower risk were predictive for not participating. Time constraint and extra burden were expressed as decisive reasons for not participating. CONCLUSIONS: Strategies to optimize research participation should be aimed at younger children and their families, who are logistically challenged and unfamiliar with health care and research. Recommendations include informing pediatric patients and their families of the value of research; minimizing logistic burdens; and improving accessibility.
Authors: Irma M Hein; Pieter W Troost; Robert Lindeboom; Marc A Benninga; C Michel Zwaan; Johannes B van Goudoever; Ramón J L Lindauer Journal: JAMA Pediatr Date: 2014-12 Impact factor: 16.193
Authors: Victoria A Miller; Justin N Baker; Angela C Leek; Sabahat Hizlan; Susan R Rheingold; Amy D Yamokoski; Dennis Drotar; Eric Kodish Journal: Pediatr Blood Cancer Date: 2012-10-03 Impact factor: 3.167
Authors: Janet L Brody; Charles W Turner; Robert D Annett; David G Scherer; Jeanne Dalen Journal: J Adolesc Health Date: 2012-03-03 Impact factor: 5.012
Authors: Irma M Hein; Pieter W Troost; Robert Lindeboom; Martine C de Vries; C Michel Zwaan; Ramón J L Lindauer Journal: BMC Pediatr Date: 2012-09-25 Impact factor: 2.125
Authors: Philip Lambrechtse; Victoria C Ziesenitz; Andrew Atkinson; Ernst Jan Bos; Tatjana Welzel; Yael Gilgen; Nicolas Gürtler; Simone Heuscher; Adam Frederik Cohen; Johannes N van den Anker Journal: Eur J Pediatr Date: 2021-01-04 Impact factor: 3.183
Authors: Leanne K Elliott; Herman Bami; Maxwell J Gelkopf; Ryan C Yee; Brian M Feldman; Y Ingrid Goh Journal: Pediatr Rheumatol Online J Date: 2019-12-21 Impact factor: 3.054